Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2026-07-30

Posted on July 30, 2026August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2026-07-30

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Wonik IPS has officially announced that it plans to disclose its Q2 2026 provisional financial results on August 6, 2026.

📊 [Key Disclosure Contents & Summary Metrics]

  • Company Name: Wonik IPS Co., Ltd.
  • Target Period: April 01, 2026 – June 30, 2026 (Q2 2026)
  • Expected Disclosure Date: August 06, 2026
  • Other Investment Considerations:
    • The earnings results will be prepared on a consolidated basis under K-IFRS.
    • Figures are provisional and subject to change depending on the external auditor’s review and internal circumstances.
    • Presentation materials related to financial results will be posted on the company website (www.ips.co.kr) after fair disclosure.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Provisional Earnings Disclosure and IR Materials

This disclosure serves as a prior notice specifying the scheduled date for the upcoming earnings release. Checking the provisional earnings figures announced on August 6 and verifying any potential discrepancies with final audited numbers is essential for accurately evaluating the company’s Q2 operational performance. Detailed financial metrics and business insights can be verified through the upcoming ‘Consolidated Financial Results (Provisional)’ disclosure, the subsequent quarterly report, and IR materials on the official corporate website.

📢 Disclaimer & Source Notice

Source: This content is structured and rewritten based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2026-07-29
Next Post: [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-07-30

Related Posts

[Disclosure] Hanwha Systems (272210) – Corrected Filing for Stock Acquisition by Subsidiary Hanwha Systems USA Corp. (Expected Date Revised to Dec 23, 2025) Disclosures
[Disclosure] SK Square (402340) – Treasury Stock Disposal Decision / 2025-10-29 Semiconductors
[Disclosure] Celltrion (068270) – Approval of US FDA Marketing Authorization for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-12-18 Disclosures
[Disclosure] Hanwha Systems (272210) Changes Head Office Address Following Completion of New Headquarters Building Disclosures
[Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2026-02-09 Semiconductors
[Disclosure] Celltrion (068270) – Approval of Part 1 & Part 2 Clinical Trial Application for Phase 3 Trial of CT-P55 (Cosentyx Biosimilar) in Europe / 2025-02-18 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme